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Rabbits  injected  subcutaneously  with  alkaline  extracts  of bovine,  hog,  or 
human anterior pituitary glands develop a markedhyperlipemia within 12 to 24 
hours,  as has  been shown recently by Rudman  and  Seidman  (1). During  the 
course of experiments here reported which were designed to learn more about the 
pathogenesis of this hyperlipemia,  it was found that injection of the pituitary 
extracts  was regularly  accompanied  by a  striking  inhibition  of  the  lipemia- 
clearing activity that normally occurs in the plasma following the intravenous 
injection  of heparin  (2).  Moreover,  relatively  small  amounts  of serum  from 
rabbits given pituitary  extracts  were capable of retarding  or abolishing  com- 
pletely  the  ability  of postheparin  plasma  obtained  from  normal  animals  to 
clear lipid emulsions.  The inhibition  of clearing paralleled  closely the severity 
of the hypexlipemia and in a number of instances preceded the onset of hyper- 
lipemia,  the findings suggesting a  possible causal connection between the two 
phenomena. 
Materials  and Metkods 
Rabbits were given a  single  subcutaneous  injection  of an extract  of either 
bovine, hog, or human anterior pituitary glands.  At varying intervals of time 
following  the  injection  the  animals  were  given  heparin  intravenously  and 
plasma obtained 15 minutes later was tested for its ability to clear a  synthetic 
lipid  emulsion.  In  other  experiments,  serum obtained  following the injection 
of pituitary  extracts was added  to postheparin plasma obtained  from normal 
animals,  and  the ability of such mixtures  to  clear a synthetic lipid  emulsion 
was assayed. In most eases, lipemia clearing  activity was measured  by reduc- 
tion in optical density; in some instances production of glycerol or non-esterified 
fatty acids was also determined. 
Pituitary F~tracts.--Bovine pituitary glands were obtained frozen from the slaughter house 
and were kept at --20°C. until used. Just prior to use, the glands were thawed, trimmed of 
* These studies were supported in part by grants from the United States Public Health 
Service and The New York Heart Association. 
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attached dura,  bone, and brain, and the posterior lobe was removed. The glands were then 
quickly frozen in a mixture of alcohol and solid carbon dioxide, and dried in vacuo from the 
frozen state. The glands were ground to a powder in a mortar and stored in a desiccator at 4°C. 
The dried pituitary powder was extracted with 0.1  N sodium hydroxide, usually in the 
proportion of 100 mg. of powder to 10 ml. of sodium hydroxide. Extraction was carried out 
at 4°C. for 30 minutes with frequent shaking. The pH of the extract was adjusted to 7.5 with 
6 N hydrochloric acid, and the insoluble residue was removed by centrifugation. The super- 
hates were stored at 4°C. until used, usually for 1 or 2 days. In a few experiments pituitary 
glands from human beings obtained from the postmortem service of The New York Hospital 
and, in more recent experiments, lyophilized swine pituitary glands  1 were used. The results 
with both these preparations  were comparable to those observed with the bovine glands. 
Rabbits.--Market-bought adult  rabbits  of mixed breeds and  both sexes were employed. 
The animals were fed a diet of Rockland rabbit pellets supplemented twice weekly with lettuce 
and carrots. This diet is low in fat and free of cholesterol. The pituitary extracts were injected 
subcutaneously between the shoulder blades in 10 or 15 ml. amounts with little or no visible 
immediate reaction on the part  of the animals. The injection sites when examined 6 to 72 
hours later showed only very slight local erythema and no other evidence of inflammatory 
reaction. 
Lipemia Clearing Actlvity.--Clearing factor was produced in rabbits  by the intravenous 
injection of heparin,*  7.5 rag.  per kilo. Fifteen minutes after injection the animals were bled 
from the marginal ear vein into conical centrifuge tubes containing 3.2 per cent sodium citrate, 
in a ratio of 9 parts blood to 1 part citrate. The tubes were inverted several times and centri- 
fuged at 4°C. for 10 minutes at a speed of 3,000 x.l,.M. The supernatant  plasma (henceforth 
referred to as postheparin plasma or PHP)* was separated  and stored in an ice bath until 
used.  In several experiments clearing factor was obtained from human beings following an 
intravenous injection of heparin in a  dose of i  rag. per kilo. 
Lipemia-clearing activity was assayed  by reduction in optical density according to the 
method of Grossman e~ a/. (3). 0.1 ml. of a  1-100 dilution in saline of a coconut oil emulsion 
(ediol 4) was placed in a  Coleman microcuvette together with 0.5  ml. of imidazole buffer at 
pH 7.4, both having been previously warmed to 37°C. 0.4 nil. of postheparin plasma was then 
added and the contents quickly mixed by inversion and the optical density read in a Coleman 
Junior spectrophotometer at a wave length of 700 m/z. The tubes were incubated in a water 
bath at 37°C. and optical density recorded at intervals of 15, 30, 60, and 90 minutes. In some 
experiments lipemla-clearing activity or its inhibition was also followed by changes in the 
liberation of glycerol according to the method of Lambert and Nelsh (4), and by the release 
of non-esterified fatty acids using the method of Dole (5). 
EXPERIMENTAL 
Hyperlipemia Induced in Rabbits  by Pituitary Extracts 
An experiment was first done to confirm the findings of Rudman  and Seidman 
that  the  injection  of  crude  pituitary  extracts  into  rabbits  results  in  the  de- 
velopment  of  hyperlipemia  (1),  and  also  to  learn  whether  extracts  of  other 
tissues could produce  similar changes. 
* The authors are indebted to Dr. J. D. Fisher of the Armour Laboratories,  Kankakee, 
Illinois, for a  generous supply of lyophilized hog pituitary glands. 
* The hepariu used in these studies was generously supplied by Dr. George H. Berryman 
of the Abbott Company, Chicago. 
* PHP, postheparin  plasma. 
* Obtained  from  SchenLabs  Pharmaceuticals,  Inc.,  New  York. A.  KELLNER~  R.  L.  HIRSCH~ AND  E.  B,  FREEMAN  3 
An extract d  lyophilized beef anterior pituitary glands was prepared so that each milliliter 
of extract represented 10 nag. of dried gland. Similar extracts were prepared from lyophili~d 
beef liver, brain, pancreas, and heart, each milliliter of extract in these cases, however, being 
equivalent to 30 nag. of the dried material. Eight rabbits were each given a single injection of 
15 nil. of beef pituitary extract. In control studies four rabbits were each given 15 ml. of an 
extract of either beef fiver, pancreas or brain, and two received 15 ml. of beef heart extract 
TABLE I 
Changes in O;plleal Density  of Blood Serum Following Injection  into Rabbits of Extracts from 
Beef Pituitary,  Liver, Pancreas, Brain,  and Heart 
Rabbit No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
1-0 
1-1 
1-2 
1-3 
1-4 
1-5 
1-6 
1-7 
1-8 
1-9 
2-0 
2-1 
2-2 
Optical density 
Extract of 
Beef pituitary* 
~  at 
~¢  CC 
Beef liver:[: 
gg  (g 
~c  ¢c 
Beef brain~: 
cC  ~# 
~L  c# 
Beef panereas~ 
~C  Cc 
Beef heart:l: 
Initial 
0.019 
0.022 
0.029 
0.020 
0.025 
0.020 
0.022 
0.023 
0.023 
0.022 
0.020 
0.016 
0.035 
0.052 
0.057 
O. 022 
0.027 
0.047 
0.047 
0.021 
0.037 
0.040 
At peak lipemia 
(1~-~ hrs.) 
0.031 
0.095 
0.188 
0.280 
0.290 
0.434 
0.628 
1.300 
0.022 
0.029 
0.016 
0.016 
0.028 
0.060 
0.028 
0.030 
0.030 
0.030 
0.023 
0.025 
0.O37 
0.036 
* Each rabbit given 15 ml. of extract subcutaneously.  Each milliliter of extract equiva- 
lent to  10 rag.  of lyophilized pituitary gland. 
:~ Each rabbit given 15 ml. of extract subcutaneously.  Each milliliter of extract equiva- 
lent  to 30  rag.  of lyophilized tissue. 
subcutaneously. The animals were bled just prior to injection and at periodic intervals there- 
after for 36 to 48 hours. Serum from the animals given pituitary extract began to be visibly 
lipemic 6 to 12 hours after injection, and reached a peak of lipemia between 16 and 24 hours. 
The sera then returned to their initial clarity within another  18 to 24 hours. The degree of 
visible lipemia varied from moderate opalescence in some cases to striking milkiness in others 
(see Table I). It is of interest that in many similar experiments comprising all told more than 
100 rabbits about one-quarter of the animals failed to develop visible lipemia following injec- 
tion of pituitary extract, and some failed to respond even after four injections. None of the INHIBITION  OF  LIPOPROTEIN  Ln~ASE 
control animals given either beef liver, pancreas, brain, or heart showed any visible lipemia 
nor any significant increase in the optical density of the blood serum (Table I). 
Similar findings, the development of visible lipemia and a sharp increase in the optical 
density of the serum, were observed following the injection into rabbits of extracts of hog 
and human pituitary glands. In a number of experiments  serum total lipid and total cholesterol 
levels were also determined. In virtually all cases there was a three- to eightfold increase in 
total lipids paralleling the increase in optical density, and a slight to moderate increase in 
total cholesterol. A typical experiment in which a rabbit was given 15 ml. of an extract of 
bovine anterior pituitary gland is illustrated in Fig. 1. 
Many of the  animals appeared to be obviously sick following injection of 
the pituitary extracts.  Within  3  hours after the injection they became weak 
and lethargic and did not eat or drink. The weakness grew progressively worse, 
particularly  in  rabbits  developing  severe  hyperlipemia,  to  the  point  where 
in some cases the paws were splayed out laterally and these animals had con- 
siderable difficulty holding their heads up. They were tachypneic and appeared 
to be in shock, for little or no blood could be obtained even when the central 
artery of the ear was severed and the few drops that didflow were dark andviscid. 
As the hyperlipemia waned  after 24 to  48  hours,  these  symptoms gradually 
subsided;  the animals began to eat and drink  and gradually recovered com- 
pletely. With some batches of the pituitary extract, however, as many as one- 
third of the injected animals sickened and died. Death occurred between 3 and 
24  hours  after  injection,  in  some  cases  prior  to  the  onset  of hyperlipemia. 
Postmortem examination failed to reveal any anatomical changes that could 
account for the  symptoms observed or death.  No  toxic symptoms were ob- 
served in the animals given extracts of beef liver,  brain,  pancreas,  or heart, 
and none died. 
It  was  evident  from  these  experiments  that  extracts  of pituitary  glands 
from beef, swine, and human beings when injected into rabbits brought about 
a marked increase in blood lipids. Extracts of liver, pancreas, brain, and heart 
had no such effect. Also, the development of hypeflipemia was  followed in a 
considerable number of instances  by a  sequence  of toxic symptoms and  oc- 
casionally even by death of the animal for which no satisfactory explanation 
was readily available. Attention was then directed to the possible pathogenesis 
of this pituitary-induced hyperlipemia. 
Inhibition of Lipoprotein Lipase Activity Following Injection of Pituitary Extracts 
The injection of heparin into the circulation results in the appearance of an 
enzyme in  the  blood  which  hydrolyzes the  triglycerides  of chylomicrons,  or 
those  of synthetic  lipid  emulsions,  to  glycerol and  non-esterified fatty acids 
(2). This heparin-induced enzyme, referred to as clearing factor or lipoprotein 
lipase,  is thought  to be one of the  mechanisms responsible normally for the 
removal of lipids from the blood stream, and there is evidence at hand  both 
in experimental animals and in human beings that interference with this enzyme 
system results in the development of hyperlipemia (6, 7). Studies were therefore A.  KELLNER,  R.  L.  HIRSCH~  AND  E.  B.  FREEMAN 
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done to learn what effect, if any,  the injection of pituitary  extracts had on the 
heparin-activated  lipernia  clearing  system. 
In a series of experiments 16 rabbits were each given a single injection of 15 rot. of a beef 
pituitary extract subcutaneously.  At varying intervals of time thereafter the animals were 
given heparin intravenously,  7.5  mg.  per kilo, and bled  15 minutes later into citrate. The 
postheparin plasmas obtained were then assayed for clearing activity. The PHP specimens 
obtained 1 hour after the injection of pituitary extract had no diminution of their clearing 
activity. Those obtained between 3 hours and 18 hours, however, all showed partial to com- 
plete inhibition of clearing, as illustrated in Fig. 2. At 24 and 30 hours, three out of four sam- 
pies of PHP had normal clearing activity again. In general, the degree of inhibition of cleating 
activity paralleled the height of the lipemia. Thus, rabbit 30-90 in Fig. 2, which showed partial 
AO.D. 
~000 
0D50 
0,100 
Rabbit  30-89 
0.150  %~e~~,~ 
Control 
'u,- =-,~ ,,-,,,= -. ,o 
I  I  =  t  I 
0.2 O0 0  1'5  30  45  60  75  90 
MINUTES 
Fzc,. 2. Inhibition of ]Jpoprotein ]Jpase production following injection of bovine pituitary 
extract. 
Rabbits 30-89 and 30-90--postheparin plasma obtained  12 hours after injection of pitui- 
tary extract. 
Control-postheparin plasma obtained from a normal rabbit. 
inhibition of clearing at 12 hours, had at the time a serum optical density of 0.072 while the 
serum of rabbit 30-89 with complete inhibition of cleating at 12 hours had an optical density 
of 0.292. It is of interest that in this and in other experiments the inhibition of lipemia-clearing 
activity often preceded by several hours the development of visible lipemia. Comparable find- 
ings were observed in studies using pituitary extract of swine and human origin. 
The end products of the hydrolysis of the triglycetides of chylomicrons by lipoprotein lipase 
are unesterified fatty acids and glycerol; the reduction in optical density is a secondary mani- 
festation of the resulting decrease in particle size.  The possibility was considered that  the 
lipolytic action of the enzyme might proceed normally following the injection of pituitary 
extract though not reflected in a reduction in optical density. An  experiment was therefore 
done in which the clearing reaction in rabbits given pituitary extracts was measured by glyc- 
erol liberation as well as by change in optical density.  Control postheparin plasma  was ob- 
tained from three rabbits and the animals were then each given 15 ml. of beef pituitary extract. 
Injection of heparin was repeated 12 hours later in the case of two of the rabbits and 18 hours 
later in the case of the third; PHP was collected and assayed for clearing factor by measuring A. KELLNER,  R. L. ;rrRSCH~ AND  E. B.  FREEMAN 
changes in optical densi  W and also the amount of glycerol produced. The results of this ex- 
periment are illustrated in Table II. The control PHP's obtained just prior to injection of the 
pituitary extract caused a sharp decline in optical density and at the end of 2 hours produced 
41 to 45 micrograms of glycerol. The PHP specimens obtained 12 hours after injection cleared 
the lipid emulsion poorly and only 11 and 17 micrograms of glycerol, respectively, were liber- 
ated. The PHP from the third rabbit, bled at the height of lipemia, 18 hours after injection 
of pituitary extract, cleared hardly at all and liberated only 6 micrograms of glycerol. Similar 
results were obtained in other experiments in which the lipolytic activity of the clearing enzyme 
was measured by release of non-esterified fatty acids.  It was plain from these experiments 
that the production of lipoprotein lipase was inhibited whether the lipolytic action was meas- 
ured by changes in optical density or by liberation of glycerol or non-esterified fatty acids. 
To make certain that failure to detect clearing activity was not due to the presence of excessive 
TABLE H 
Inhibition  of Lipoprotein  Lipa~e Aaivity Following Injeaion  of Beef Pituitary Extracts 
Rabbit No.  Time PHP obtained  Clearing activity*  Glycerol  produced 
Control 
12 hrs. 
Control 
12 hrs. 
Control 
18 hrs. 
0.250 
0.122 
0.243 
0.156 
O. 226 
0.021 
45 
17 
44 
11 
41 
5 
10 ml.  beef pituitary extract  given subcutaneously to each of 3  rabbits. 
PHP--postheparin plasma obtained 15 minutes after heparin,  7.3  rag.  per kilo intra- 
venously. Heparin given and PHP obtained twice from each rabbit; once just prior to in- 
jection of pituitary extract  (control) and again 12 or 18 hours later. 
The clearing system contained 0.4 mi. PHP, 0.1 ml. ediol 1-100, and 0.5 ml. buffer.  Op- 
tical density and glycerol production determined at 0  and at  2  hours. 
* Clearing activity measured by reduction in optical density. 
amounts of free fatty acids connected with the developing hyperlipemia, amounts of free 
fatty acid equivalent to those present in the lipemic serum were added to PI:IP from a normal 
rabbit, and only slight impairment of clearing activity resulted. In a further control experi- 
ment, bovine serum albumin was added to the PHP from lipemic rabbits in order to provide 
additional fatty acid acceptors, and no enhancement of clearing was observed. 
Control Studies With Extracts of Beef Liver, Brain,  Pancreas, and He.art.--Extracts  of beef 
liver, brain, pancreas, and heart in doses three to five times as great as those of pituitary ex- 
tract were injected subcutaneously into groups of four rabbits each. The animals were given 
heparin intravenously  at intervals of 3 to 24 hours after injection and the PI=IP assayed for 
clearing activity. No inhibition  of clearing was demonstrable in any of these studies. 
These  experiments  demonstrated  that  the  injection  of  pituitary  extracts 
into rabbits interfered in some manner with the ability of the animals to elab- 
orate active clearing factor in response to the intravenous injection of heparin. INHIBITION O~  LIPOPROTEIN LIPASE 
Moreover, the impairment of the formation of clearing factor appeared to be 
associated with the development of visible lipemia, and often preceded it. An 
experiment was next done to learn whether serum from rabbits given pituitary 
extracts could inhibit in vitro the clearing activity of postheparin plasma from 
normal rabbits. 
Inhibition of Clearing Actidty in Vitro By Lipemic Serum from Rabbits Given 
Pituitary Extracts.--Lipemic  serum from a  rabbit given pituitary  extract  18 
hours previously was added  in  amounts of 0.01,  0.02,  0.05,  and 0.1  ml.,  re- 
spectively, to clearing mixtures containing 0.4 ml. PHP from a normal rabbit 
and 0.1  ml. of diluted  ediol.  The total volume of each clearing  mixture was 
brought to 1.0 ml. with buffer solution. The control clearing mixture contained 
0.1  ml. of normal rabbit serum but no lipemie serum. The results of this ex- 
LIPEMIC 
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FIG. 3. Inhibition of clearing activity of postheparin plasma from a normal rabbit by means 
of lipemic serum obtained from a rabbit given pituitary extract. 
periment, shown in Fig.  3, demonstrate that  clearing was almost completely 
inhibited by 0.05  and 0.1  ml. of lipemic serum, and significantly though only 
partially inhibited by as little as 0.01 ml. of lipemic serum.  In further studies 
the  development  of inhibitor  to  lipoprotein  lipase  in  the  serum  of injected 
rabbits was found to parallel closely the changes in the turbidity of the serum 
(see Fig. 4). In other experiments it was found that the lipemia clearing activity 
of postheparin plasma from human beings was also readily inhibited in vitro 
by  small  amounts  of  lipemic  serum  obtained  from  rabbits  given  pituitary 
extracts. 
Failure of Beef Pituitary Extract to InMbit the Cleaving Reaction in Vitro.--An extract of 
beef pituitary  glands, previously shown to be capable of inducing lipernia and inhibition of 
clearing activity when injected into rabbits, was added in ~tro in varying amounts to a clear- 
ing system containing posthgparin plasma from a normal rabbit. As shown in Table III, the A.  KELLNER~  R.  L.  HIRSCH,  AND  E.  B.  FREEMAN 
pituitary extract itself in amounts up to 0.1 ml. failed to inhibit clearing.  This indicated 
strongly that inhibition of clearing  was not due to something contained in the pituitary extract 
itself but rather to something produced in vivo following injection of the extract. 
SERUM  INHIBITION 
TURBIDITY  OF  CLEARING 
(o. D)  (l~;oucnoN  IN  O:O4 
0.9 0  0.00 
0.05 
0.60 
0.10 
O.30 
0.15 
0"000  5  6  9  12  15  16  21'  '  24  27  ~,3.20 
HOURS 
FIG. 4. Changes in turbidity and the development of an inhibitor to clearing in the serum 
of a rabbit given pituitary extract. Inhibition of clearing was measured by adding 0.2 ml. 
of serum from the test animal to a mixture containing 0.4 ml. of postheparin plasma from a 
normal rabbit, 0.1 ml. of ediol, and 0.3 ml. of buffer. 
TABLE HI 
Failure  of Beef Pituitary Extracts  to Inhibit Lipoprolein  Lipase  Activity in  Vitro 
Optical density 
Time  Beef pituitary extract 
0  0.04 ml.  0.06 ml.  0.08 ml.  0,1 ml, 
0 
15 
30 
6O 
90 
O. 240 
0.085 
0.043 
0.030 
0.030 
0.219 
0.063 
0.041 
0.030 
0.027 
0.230 
0.080 
0.050 
0.040 
0.039 
0.229 
0.085 
0.045 
0.039 
0.033 
0.245 
0.133 
0.064 
0.047 
0.032 
Each clearing mixture contained 0.4 ml. postheparin plasma from a normal rabbit, 0.1 ml. 
ediol 1-100,  the stated amount of bed pituitary extract, and buffer  to bring the volume 
to 1.0 ml. 
Taken  together,  these  findings  indicate  that  an  inhibitor  of  lipoprotein 
lipase activity appears in the blood of rabbits a  few hours a/ter the injection 
of pituitary extracts. This inhibitor prevents the elaboration of active clearing 
factor when  hepa~in is injected into  the  animal  and  also  suppresses  in ~ro 
the activity of clearing enzyme obtained from normal animals or human beings. 10  INHIBITION  O~"  LIPOPROTEIN LrPASE 
Failure  of Lipemic  Serum  to  Inhibit  the  Anticoagulant  Effect  of lteparin.-- 
Lipoprotein lipase is thought to contain heparin as an integral part of its struc- 
ture, and agents such as protamine sulfate or heparinase which antagonize or 
destroy heparin also abolish the lipolytic action of the enzyme (8). In view of 
this,  the  possibility was  considered  that  the  inhibition  of  lipoprotein lipase 
activity herein described could be due to the presence of a  hepafin antagonist 
in  the  serum  of rabbits  given pituitary extracts.  To  explore  this  possibility 
further, a number of experiments were done in which lipemic serums capable of 
inhibiting completely the  lipolytic action of clearing factor were  assayed for 
their effect on the anticoagulant action of heparin. 
TABLE IV 
Recalcification Time of Dilutions  of Iteparin Incubated with Normal Rabbit Serum  and with 
Lipemic  Serum  from  a  Rabbit Given Pituitary  Extract 
Dilution of heparin 
1-100 
1-200 
1-300 
1-400 
1-500 
1-750 
1-1000 
Recalcification  time (mls.:s~.) 
Normal serum 
30:00 
30:00 
9:31 
7:16 
4:06 
3:26 
2:35 
Lipemic  serum 
30:00 
30:00 
9:02 
10:39 
7:27 
4:13 
2:57 
0.1 ml. of normal serum or lipemic serum incubated with 0.1 ml. of each dilution of heparin 
for 15 minutes at 37°C. 0.4 ml. of normal citrated rabbit plasma and 0.25 ml. of 0.05 ~ CaCls 
added to each tube for determination of recalcification  time. 
In these experiments,  0.1 ml. of lipemic serum from a rabbit given pituitary extract was 
incubated for 15 minutes at 37°C. with 0.1 ml. of each of a series of dilutions of hepaxin from 
1:100  to 1:1000. A parallel control series contained 0.1 ml. of normal rabbit serum incubated 
with the heparin dilutions. 0.4 ml. of normal citrated rabbit plasma and 0.25 ml. of 0.05 M 
CaC12 were added to each tube and the recalcification time determined. The data from several 
such experiments,  one of which is illustrated in Table IV, demonstrated no significant differ- 
ence between the recalcification times of heparin dilutions incubated with normal serum and 
those incubated with lipemic serum. 
It was evident from these findings that the serum of rabbits given pituitary 
extracts  did not  alter the  anticoagulant effect of heparin in  vitro,  indicating 
that  the ability of such  sera to inhibit lipoprotein lipase was not due  to the 
presence of heparin antagonists. 
Charaaerization  of the  Inhibitor.--Preliminary  studies  of  the  inhibitor  de- 
tected in the serum of rabbits given pituitary extracts revealed it to have the 
following characteristics. Dialysis against running tap water overnight had no A.  KELLNER~  R.  L.  HIRSCH~ AND  E.  B.  ~REEMAN  11 
effect on its ability to inhibit lipoprotein lipase.  Its potency was unimpaired 
by storage at 4°C. for 3 weeks or heating at 70°C. for 30 minutes. It was re- 
sistant to enzymatic degradation by trypsin, papaln,  and pepsin. Absorption 
with barium sulfate did not diminish  the inhibitory activity. After centrifuga- 
tion of Upemic serum at 30,000  ~t.p.M. for 1 hour, virtually all the inhibitor 
was present in  the supernatant  fat layer.  Extraction  of lipemic  serum with 
chloroform or petroleum ether failed to remove the inhibitor. Taken together, 
these findings point to the inhibitor as being a stable, large molecular substance 
of relatively low density,  probably a  lipoprotein. 
DISCUSSION 
The findings herein described confirm fully the observation made by Rudman 
and Seidman that  the injection of crude pituitary extracts into rabbits leads 
to the development of a striking hypeflipemia (1). Subsequent studies by these 
investigators have indicated that the active material in the extracts is a protein 
separate from the known hormones of the anterior pituitary and probably repre- 
sents a new pituitary hormone (9). 
The initial reports of Rudman and Seidman make no mention of toxic symp- 
toms in  their  animals  following  injection  of the  pituitary  extracts.  In  the 
experiments reported in this paper approximately one-third of the animals sick- 
ened within a  few hours after injection and not a few died. Postmortem ex- 
aminations failed to reveal any lesions that could explain  the sickness or death 
of these animals,  and no evidences of sickness and no deaths were observed in 
numerous control animals given injections of extracts made from tissues other 
than  the pituitary.  A  possible explanation  for these  toxic sequelae was the 
lowering  of  tissue  oxygen  tension  attendant  upon  the  rapidly  developing 
lipemia,  as has been shown recently by Joyner el a/.  (10).  However, some of 
the animals sickened and died prior to the onset of lipemia, and in other studies 
in which rabbits were given triton intravenously,  comparable lipemia ensued 
without evidence of toxicity (11). A more likely explanation is an interference 
with the ability of the animals  to utilize fatty acids and glucose  for energy 
purposes following the injection of pituitary extracts. In this connection, it is 
of interest that a sharp increase in the plasma non-esterified fatty acids followed 
regularly within 1 hour after the injection of pituitary extract into rabbits; the 
fatty acids reached peak levels,  often 10 to 20 times the baseline,  at 3 to 5 
hours, and returned to the normal range usually within 12 hours (12). A block 
in the utilization of fatty acids at the cellular  level may perhaps be the initial 
event mediated by the pituitary extracts, resulting in the rapid accumulation 
of non-ester[fled  fatty acids in the plasma and  the eventual development of 
lactescence and hyperlipemia. In many animals there was also a concomitant 
increase  in  blood glucose,  the  hyperglycemia  occasionally persisting  for  as 
long  as 48 to  72 hours.  Furthermore,  studies on the metabolism of isolated 12  INHIBITION  O~"  LIPOPROTEIN LIPASE 
tissues removed from animals given various pituitary preparations have demon- 
strated a significant  reduction in glucose uptake and impairment of fatty acid 
catabolism (13,  14).  Since fatty acids and glucose represent the major if not 
the sole sources of energy available to the animal,  the interposition of a meta- 
bolic block hampering  their  conversion  into  energy could result in profound 
weakness, shock, and even death. 
It is clear from these studies that the pituitary extracts employed contained 
an agent or agents, the nature of which is still undetermined, which upon in- 
jection into the animal body caused the liberation of a substance that inhibits 
the enzymatic action of lipoprotein lipase.  An inhibitor of the clearing  system 
has been previously described by Seifter and Baeder (15) in the serum of rats 
after experimental  induction  of the nephrotic  syndrome and  after  cortisone 
injections; the inhibitor in those cases, however, was dialyzable and that here 
reported is not. An inhibitor has also been isolated from normal dog serum by 
Hollett and Meng  (16)  and found to be a  glycoprotein. The inhibitor  found 
in rabbit serum following injection of pituitary extracts appears to be a lipo- 
protein. Moreover, extraction of such rabbit serum known to contain inhibitor 
of lipoprotein lipase using the procedure described by Hollett and iYIeng failed 
to yield any inhibitor. 
There appeared to be a very close relationship between the development of 
hyperlipemia and the appearance of inhibitor  to lipoprotein lipase.  In every 
instance  in  which  hyperlipemia followed  injection  of pituitary  extracts,  the 
inhibitor could also be readily demonstrated in the serum. Conversely, in those 
animals  in which lipemia did not ensue,  little or no inhibitor  was present in 
the  serum.  The  appearance  and  disappearance  of visible lipemia  paralleled 
closely  the rise  and fall  of inhibitor  activity, and those cases with the most 
striking lipemia generally also had the highest titer of inhibitor. The fact that 
in some instances the inhibitor  appeared prior to the development of hyper- 
lipemia  suggested that  the inhibitor  might  be responsible  for the increase  in 
serum  lipids.  A  causal  connection  between  inhibition  of  lipoprotein  lipase 
activity and  the  development  of lipemia  has  been shown  by Bragdon  and 
Havel (6) in rats given protamine  and has also been reported in some cases of 
essential  hyperlipemia in human  beings  (7).  However, the fact that  the in- 
hibitor did not regularly appear before the onset of visible lipemia  makes the 
causal relationship between the two uncertain for the present. Also, the ques- 
tion  as to whether both phenomena  result from the same or from different 
factors present in the pituitary extracts cannot be decided until further puri- 
fication  of the  extracts has  been accomplished. 
suMMARY 
Rabbits given a single  subcutaneous injection  of an alkaline  extract  of hog, 
bovine, or human anterior  pituitary  glands developed marked hyperlipenda A. KELLNER, R. L. HIRSCH, AND E. B. FREEMAN  13 
within 12 to 24 hours. The injections in some instances were followed by sick- 
ening and death of the animal, though no anatomical changes responsible for 
these consequences could be determined. No such sequelae were observed in 
animals given much larger injections of comparable extracts made from other 
tissues. 
An inhibitor to lipoprotein lipase  appeared  regularly in the serum of the 
injected animals in association with the hyperlipemia. The injection of heparin 
into such  animals failed to result in the elaboration of clearing factor, and 
serum from these animals inhibited in vilro the hydrolysis of lipid emulsions 
by active lipoprotein lipase obtained from normal rabbits  or human beings. 
The inhibitor was produced only in vivo by the pituitary extracts. It did not 
antagonize the anticoagulant action of heparin, and is probably a lipoprotein. 
The authors wish to express their appreciation  to Miss Eva Buschke  and to Miss Rosemary 
Ireland for valuable technical assistance. 
BIBLIOGRAPHY 
1.  Rudman, D.,  and  Seidman,  F.,  Lipemia  in  the  rabbit  following injection  of 
pituitary extract, Proc. Soc. .Exp. Biol.  and Med,,  1958, 99,  146. 
2.  Korn, E. D., Clearing factor, a heparin-activated  lipoprotein lipase, I. Isolation 
and characterization  of the enzyme from normal rat heart; II. Substrate speci- 
ficity and activation of coconut oil, J. Biol.  Chem., 1955, 215,  1. 
3.  Grossman, M. I., Stadler,  J., Cushing, A., and Palm, L., Relation of lipolysis 
to deturbidifieation  and returbidification  in heparin-induced  lipemia-clearing 
phenomenon,  Proc. Soc. Exp. Biol.  amt Med.,  1955, 88,  132. 
4.  Lambert, M., and Neish, A. C., Rapid method for estimation of glycerol in fer- 
mentation solutions, Canad. ]. Research, 1950, 20, 83. 
5.  Dole,  V.  P.,  A relation  between  non-esterified fatty acids  in plasma  and the 
metabolism  of glucose, 1.  Clin. Inv.,  1956, 85,  150. 
6.  Bragdon, ]. H., and Havel, R. ]., In vivo effect of anti-heparin  agents on serum 
lipids and lipoproteins,  Am..[. Physiol.,  1954, 177, 128. 
7.  Havel, R. J., and Gordon, R. S., Jr., An enzymatic defect associated with altered 
lipoprotein  metabolism  in an individual  with idiopathic hyperlipemia, Circu- 
lation, 1955, 12, 485. 
8.  Korn, E. D., Partial inactivation of lipoprotein lipase by bacterial  "heparinase," 
Science, 1956, 124, 489. 
9.  Rudman, D.,  Seidman,  F., and Reid,  M.  B.,  Identification of substances  re- 
sponsible for lipemia-producing activity of pituitary gland,  Circulation, 1959, 
20, 968. 
10.  Joyner, C.  R., Horwitz,  O.,  and Williams,  P.  G.,  Effect of lipemia  on tissue 
oxygen tension, Circulation, 1959, 9.0, 716. 
11.  KeUner, A.,  Correll, J.  W., and Ladd, A. T.,  Sustained  hyperlipemla  induced 
in rabbits by means of intravenously injected  surface-active  agents,  J. Exp. 
Med.,  1951, 93, 373. 
12.  Kellner, A., Hirsch,  R. L., and Freeman,  E. B., unpublished  observations. 14  INHIBITION OF  LIPOPROTEIBT  LIPASE 
13.  Krahl,  M.  E.,  Effect of pituitary hormones  on metabolism  of isolated  tissues, 
in The Hypophyseal Growth Hormone, Nature and Actions  (R.  W.  Smith, 
Jr., O. H.  Gaebler,  C.  N. H. Long, editors),  New York, McGraw-Hill  Pub- 
lishing Co., Inc., 1955, 369. 
14.  Greenbaum,  A. L., Growth hormone and fat metabolism,  in The Hypophyscal 
Growth Hormone, Nature and Actions,  (R.  W.  Smith,  Jr.,  O.  H.  Gaebler, 
C. N. H. Long, editors),  New York, McGraw-HiU Publishing  Co., Inc., 1955, 
330. 
15.  Seifter, J., and Baeder, D. H., Occurrence in plasma of an extractable lipid mo- 
bilizer  (LM), Proc. Soc. Exp. Biol.  and Med., 1956, 91, 42. 
16. ttollett,  C.,  and  Meng,  It.  C.,  Purification and  characterization of a  lipemia 
denting  factor inhibitor from normal plasma,  in  Third International  Con- 
ference on Biochemical Problems.  Blood Lipids and Clearing Factor, Brussels, 
Paleis der Academi~n, 1956, 190. 